Division of Neurosurgery, Shizuoka Cancer Center.
Department of Neurosurgery, Shiga University of Medical Science.
Neurol Med Chir (Tokyo). 2022 Feb 15;62(2):80-88. doi: 10.2176/nmc.oa.2021-0209. Epub 2021 Oct 29.
Abnormal hypertrophic arachnoid membranes are often observed in the brain-meningioma interface during microsurgery. They contain fibrosis and tumor cell clusters; however, preservation of the membranes does not always cause recurrence from the brain surface, and the optimal treatments in the interface remain unclear. We investigated the incidence of recurrence on the brain surface following extra-arachnoid dissection with an approach emphasizing preservation of the arachnoid membranes in meningiomas of World Health Organization (WHO) Grade I. The features of dissection cleavages in the interface were prospectively recorded at surgery. The patients were followed up with MR imaging regularly. In total, 111 patients were included. The median follow-up time was 97.0 (interquartile range [IQR] 70.0-124.0) months. The cleavages in the interface were classified into three subgroups: the Extra-H group (n = 56) with extra-arachnoid resection and preservation of hypertrophic arachnoid membranes, the Extra-N group (n = 39) with extra-arachnoid resection having normal membranes, and the Subpial resection group (n = 16). Tumors recurred in 13 (11.7%) patients at both the brain and dura mater (n = 1) or at the dura mater alone (n = 12). The median recurrence-free survival (RFS) of all recurrences was significantly related to the Simpson grades (P <0.01). For brain surface recurrence, the median RFS was not related to the subgroups. The Karnofsky Performance Scores (KPSs) significantly improved in the patients except for the Subpial group at 3 months after surgery. This study revealed that hypertrophic arachnoid membranes preserved on the brain surface rarely caused recurrence from the brain in WHO Grade I meningiomas after a long-term follow-up.
在显微镜下手术中,经常可以在脑-脑膜瘤界面观察到异常增生的蛛网膜膜。它们包含纤维化和肿瘤细胞簇;然而,保留这些膜并不总是会导致从脑表面复发,并且界面处的最佳治疗方法仍不清楚。我们研究了在强调保留 I 级世界卫生组织(WHO)脑膜瘤蛛网膜膜的情况下,额外蛛网膜下剥离后脑表面复发的发生率。在手术中前瞻性地记录界面处的剥离裂隙特征。患者定期接受磁共振成像(MRI)随访。总共纳入 111 例患者。中位随访时间为 97.0(四分位距 [IQR]70.0-124.0)个月。界面裂隙分为三组:Extra-H 组(n=56)行额外蛛网膜下切除并保留肥厚蛛网膜膜,Extra-N 组(n=39)行额外蛛网膜下切除且正常膜保留,Subpial 切除组(n=16)。13 例(11.7%)患者的肿瘤在脑和硬脑膜(n=1)或硬脑膜(n=12)均复发。所有复发的中位无复发生存期(RFS)与 Simpson 分级显著相关(P<0.01)。对于脑表面复发,中位 RFS 与亚组无关。除 Subpial 组外,所有患者的 Karnofsky 表现评分(KPS)在手术后 3 个月时均显著提高。这项研究表明,在长期随访中,肥厚的蛛网膜膜保留在 I 级脑膜瘤的脑表面很少导致复发。